Fort Washington, PA USA

Our News on Newswise

NCCN to Host 9th Annual Congress: Hematologic Malignancies™ in New York, NY

The National Comprehensive Cancer Network® (NCCN®) will host its 9th Annual Congress: Hematologic Malignancies™ in New York, NY, September 19 – 20, 2014.
28-Aug-2014 10:30 AM EDT

NCCN Offers Free Webinars for Patients with Non-Small Cell Lung Cancer

On August 16, 2014, NCCN will host the second of two free patient information webinars designed to allow patients and their caregivers the opportunity to listen to live expert discussions about non-small cell lung cancer.
28-Jul-2014 1:00 PM EDT

NCCN to Host Policy Summit Addressing the Impact of Health Care Reform on Academic Oncology Practice

On July 10, 2014, NCCN will host the NCCN Policy Summit: The Impact of Health Care Reform on Academic Oncology Practice, at The Westin Arlington Gateway in Arlington, Virginia, as part of the NCCN Oncology Policy Program.
30-Jun-2014 2:00 PM EDT

NCCN Offers Free Patient Assistance Resource App

NCCN has launched its Reimbursement Resource App, which offers patients, providers, case managers, and payers access to payment assistance and reimbursement programs for multiple cancer types; the app is available free of charge for Apple and...
18-Jun-2014 12:05 PM EDT

Six Organizations Receive Grants from NCCN and Pfizer for Health Care Quality Improvement Programs in Rare Cancers

The NCCN Oncology Research Program (ORP) and Pfizer Independent Grants for Learning & Change have awarded six independent grants to implement quality improvement and health care professional education in renal cell carcinoma and hematologic...
5-Jun-2014 11:10 AM EDT

NCCN Foundation® Awards Grants to Five Young Investigators

The NCCN Foundation® has awarded the fourth series of Young Investigator Awards to five young investigators from NCCN Member Institutions; the awards provide grants of $150,000 over a two-year period for research initiatives focused on assessing...
29-May-2014 10:00 AM EDT

NCCN Receives $2 Million in Research Funding from Boehringer Ingelheim to Study Volasertib* in Hematologic Malignancies

The NCCN Oncology Research Program (ORP) received a $2-million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to facilitate studies of volasertib in hematologic malignancies.
22-May-2014 10:15 AM EDT

NCCN Publishes Comprehensive Stage-Specific Breast Cancer Resources for Patients

New NCCN Guidelines for Patients®: Breast Cancer Stages 0 – IV now available free-of-charge at; NCCN Guidelines for Patients® are educational resources that offer patient-friendly treatment information.
5-May-2014 10:30 AM EDT

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos